• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻抗-pH 监测对罗马 III 标准在区分功能性烧心和非糜烂性反流病中的附加价值。

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy; Division of Gastroenterology, IRCCS Istituto Clinico Humanitas, Milan, Italy.

出版信息

Dig Liver Dis. 2011 Jul;43(7):542-7. doi: 10.1016/j.dld.2011.01.016. Epub 2011 Mar 3.

DOI:10.1016/j.dld.2011.01.016
PMID:21376679
Abstract

INTRODUCTION

Functional heartburn is defined by Rome III criteria as an endoscopy-negative condition with normal oesophageal acid exposure time, negative symptom association to acid reflux and unsatisfactory response to proton pump inhibitors. These criteria underestimated the role of non-acid reflux.

AIM

To assess the contribution of impedance-pH with symptom association probability (SAP) analysis in identifying endoscopy-negative patients with reflux disease and separating them from functional heartburn.

METHODS

Consecutive endoscopy-negative patients treated with proton pump inhibitors (n=219) undergoing impedance-pH monitoring off-therapy were analysed. Distal acid exposure time, reflux episodes, SAP and symptomatic response to proton pump inhibitors were measured.

RESULTS

Based on impedance-pH/SAP, 67 (31%) patients were pH+/SAP+, 6 (2%) pH+/SAP-, 83 (38%) hypersensitive oesophagus and 63 (29%) functional heartburn. According to pH-metry alone/response to proton pump inhibitors, 62 (28%) were pH+/SAP+, 11 (5%) pH+/SAP-, 61 (28%) hypersensitive oesophagus and 85 (39%) functional heartburn. In the normal-acid exposure population the contribution of impedance-pH/SAP compared to pH-metry alone/response to proton pump inhibitors in identifying patients with reflux disease and functional heartburn resulted to be 10%. In patients with abnormal-acid exposure, the contribution of impedance-pH/SAP increased by 3%.

CONCLUSION

Comparing impedance-pH testing with pH-metry alone plus the response to proton pump inhibitor therapy demonstrated that the latter ones cause underestimation of reflux disease patients and overestimation of functional heartburn patients.

摘要

简介

根据罗马 III 标准,功能性烧心被定义为内镜阴性,食管酸暴露时间正常,酸反流与症状无关联,质子泵抑制剂治疗效果不佳。这些标准低估了非酸性反流的作用。

目的

评估阻抗-pH 与症状关联概率(SAP)分析在识别内镜阴性反流病患者中的作用,并将其与功能性烧心区分开来。

方法

分析了连续接受质子泵抑制剂(PPI)治疗的内镜阴性患者(n=219),这些患者在停药期间进行阻抗-pH 监测。测量远端酸暴露时间、反流事件、SAP 和质子泵抑制剂的症状反应。

结果

根据阻抗-pH/SAP,67(31%)例患者为 pH+/SAP+,6(2%)例 pH+/SAP-,83(38%)例为高敏感食管,63(29%)例为功能性烧心。根据 pH 监测/质子泵抑制剂的反应,62(28%)例为 pH+/SAP+,11(5%)例 pH+/SAP-,61(28%)例为高敏感食管,85(39%)例为功能性烧心。在正常酸暴露人群中,与 pH 监测/质子泵抑制剂的反应相比,阻抗-pH/SAP 对识别反流病和功能性烧心患者的贡献增加了 10%。在酸暴露异常的患者中,阻抗-pH/SAP 的贡献增加了 3%。

结论

与 pH 监测/质子泵抑制剂的反应相比,阻抗-pH 检测更能准确识别反流病患者,而低估了功能性烧心患者。

相似文献

1
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.阻抗-pH 监测对罗马 III 标准在区分功能性烧心和非糜烂性反流病中的附加价值。
Dig Liver Dis. 2011 Jul;43(7):542-7. doi: 10.1016/j.dld.2011.01.016. Epub 2011 Mar 3.
2
The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.治疗中阻抗-pH 参数定量分析在鉴别难治性非糜烂性反流病与功能性烧心中的附加价值。
Neurogastroenterol Motil. 2012 Feb;24(2):141-6, e87. doi: 10.1111/j.1365-2982.2011.01800.x. Epub 2011 Oct 12.
3
Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?对难治性反流症状患者进行食管pH阻抗监测:质子泵抑制剂是“服用”还是“停用”?
Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5.
4
The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.非酸性反流在NERD中的作用:来自150例停止治疗患者的阻抗- pH监测的经验教训。
Am J Gastroenterol. 2008 Nov;103(11):2685-93. doi: 10.1111/j.1572-0241.2008.02119.x. Epub 2008 Sep 4.
5
Overweight is a risk factor for both erosive and non-erosive reflux disease.超重是侵蚀性和非侵蚀性反流病的一个风险因素。
Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22.
6
[Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].[非糜烂性胃食管反流病。临床类型的发生率、食管酸暴露特征及症状相关性]
Rev Gastroenterol Mex. 2003 Apr-Jun;68(2):113-9.
7
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?质子泵抑制剂反应者,经阻抗和 pH 监测未被确认为 GERD 患者:他们是谁?
Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221. Epub 2013 Aug 29.
8
24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.24 小时动态 pH 监测在难治性烧心患者中的应用:一项前瞻性研究。
J Gastrointestin Liver Dis. 2009 Mar;18(1):11-5.
9
Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.在接受质子泵抑制剂(PPI)治疗的患者中,将食管阻抗监测添加到pH监测中可提高症状关联分析的检出率。
Am J Gastroenterol. 2006 Mar;101(3):453-9. doi: 10.1111/j.1572-0241.2006.00427.x. Epub 2006 Feb 8.
10
Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.质子泵抑制剂治疗对胃食管反流病(GERD)患者症状及生活质量的影响取决于症状与反流的关联。
J Clin Gastroenterol. 2008 May-Jun;42(5):441-7. doi: 10.1097/MCG.0b013e318074dd62.

引用本文的文献

1
Management of Patients With Refractory Reflux-Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence-Based Consensus Statements.尽管接受质子泵抑制剂治疗仍有难治性反流样症状患者的管理:循证共识声明
Aliment Pharmacol Ther. 2025 Feb;61(4):636-650. doi: 10.1111/apt.18420. Epub 2024 Dec 30.
2
Updates to the modern diagnosis of GERD: Lyon consensus 2.0.胃食管反流病现代诊断的更新:里昂共识 2.0。
Gut. 2024 Jan 5;73(2):361-371. doi: 10.1136/gutjnl-2023-330616.
3
Esophageal Reflux Hypersensitivity: A Comprehensive Review.食管反流过度敏感:全面综述。
Gut Liver. 2023 Nov 15;17(6):831-842. doi: 10.5009/gnl220373. Epub 2023 Jan 2.
4
GERD-related chronic cough: Possible mechanism, diagnosis and treatment.胃食管反流病相关慢性咳嗽:可能的机制、诊断与治疗
Front Physiol. 2022 Oct 20;13:1005404. doi: 10.3389/fphys.2022.1005404. eCollection 2022.
5
Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis.内镜阴性反流病抑酸药物治疗的比较:系统评价和网络荟萃分析。
Neurogastroenterol Motil. 2023 Jan;35(1):e14469. doi: 10.1111/nmo.14469. Epub 2022 Sep 25.
6
Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease.用于诊断胃食管反流病的夜间平均基础阻抗和反流后吞咽诱导蠕动波指数的临床应用。
Esophagus. 2022 Oct;19(4):525-534. doi: 10.1007/s10388-022-00933-6. Epub 2022 Jun 29.
7
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease.《2020年胃食管反流病诊断与管理首尔共识》
J Neurogastroenterol Motil. 2021 Oct 30;27(4):453-481. doi: 10.5056/jnm21077.
8
Diagnostic yield and reliability of post-prandial high-resolution manometry and impedance-ph for detecting rumination and supragastric belching in PPI non-responders.餐后高分辨率测压和阻抗-pH 检测对 PPI 无反应者中反刍和胃上嗳气的诊断率和可靠性。
Neurogastroenterol Motil. 2021 Oct;33(10):e14106. doi: 10.1111/nmo.14106. Epub 2021 Mar 9.
9
Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease.游离脂肪酸受体3和游离脂肪酸受体4在胃食管反流病中的表达增加。
J Clin Med. 2020 Dec 20;9(12):4111. doi: 10.3390/jcm9124111.
10
[Esophageal pH-impedance monitoring of reflux patterns in non-erosive reflux disease, reflux hypersensitivity and functional heartburn].[非糜烂性反流病、反流高敏症和功能性烧心反流模式的食管pH阻抗监测]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Oct 30;40(10):1507-1512. doi: 10.12122/j.issn.1673-4254.2020.10.18.